HALEY FRAZIER: Open Payments
NPI 1366910036 · SCOTTSDALE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,023 in 133 payments from 20 companies in 2025. Trend: 2023 $1,396 · 2024 $1,925 · 2025 $3,023
Food & beverage: $3,023
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 13 | $364 |
| Organon LLC | 23 | $362 |
| Janssen Biotech, Inc. | 11 | $359 |
| LEO Pharma Inc. | 9 | $306 |
| Regeneron Healthcare Solutions, Inc. | 7 | $209 |
| GENZYME CORPORATION | 6 | $202 |
| E.R. Squibb & Sons, L.L.C. | 5 | $199 |
| ABBVIE INC. | 13 | $199 |
| Galderma Laboratories, L.P. | 17 | $191 |
| Botanix SB Inc | 6 | $167 |
Products named: DUPIXENT, Bimzelx, TREMFYA, VTAMA, ANZUPGO, Sotyktu, NEMLUVIO, SOFDRA.
Industry payments across AZ — which companies pay providers there.
